Article, 2024

Akkermansia muciniphila exoglycosidases target extended blood group antigens to generate ABO-universal blood

Nature Microbiology, ISSN 2058-5276, Volume 9, 5, Pages 1176-1188, 10.1038/s41564-024-01663-4

Contributors

Jensen, Mathias 0000-0002-8760-6616 [1] Stenfelt, Linn 0000-0003-0196-1367 [1] [2] Ricci Hagman, Jennifer [2] [3] Pichler, Michael Jakob 0000-0003-3408-652X [1] Weikum, Julia [1] Nielsen, Tine Sofie [1] Hult, Annika K 0000-0002-2503-7016 [3] Morth, Jens Preben Preben 0000-0003-4077-0192 [1] Olsson, Martin L 0000-0003-1647-9610 (Corresponding author) [2] [3] Abou Hachem, Maher 0000-0001-8250-1842 (Corresponding author) [1]

Affiliations

  1. [1] Technical University of Denmark
  2. [NORA names: DTU Technical University of Denmark; University; Denmark; Europe, EU; Nordic; OECD];
  3. [2] Lund University
  4. [NORA names: Sweden; Europe, EU; Nordic; OECD];
  5. [3] Scania Regional Council
  6. [NORA names: Sweden; Europe, EU; Nordic; OECD]

Abstract

Matching donor and recipient blood groups based on red blood cell (RBC) surface ABO glycans and antibodies in plasma is crucial to avoid potentially fatal reactions during transfusions. Enzymatic conversion of RBC glycans to the universal group O is an attractive solution to simplify blood logistics and prevent ABO-mismatched transfusions. The gut symbiont Akkermansia muciniphila can degrade mucin O-glycans including ABO epitopes. Here we biochemically evaluated 23 Akkermansia glycosyl hydrolases and identified exoglycosidase combinations which efficiently transformed both A and B antigens and four of their carbohydrate extensions. Enzymatic removal of canonical and extended ABO antigens on RBCs significantly improved compatibility with group O plasmas, compared to conversion of A or B antigens alone. Finally, structural analyses of two B-converting enzymes identified a previously unknown putative carbohydrate-binding module. This study demonstrates the potential utility of mucin-degrading gut bacteria as valuable sources of enzymes for production of universal blood for transfusions.

Keywords

ABO, ABO antigens, ABO glycans, ABO-mismatched transfusions, Akkermansia muciniphila, B antigen, O-glycans, O-plasma, analysis, antibodies, antigen, bacteria, blood, blood cells, blood group, blood group antigens, carbohydrate, carbohydrate extensions, cells, combination, compatibility, conversion, conversion of A, donor, enzymatic conversion, enzymatic removal, enzyme, epitopes, extension, fatal reactions, glycans, glycosyl hydrolases, group, group O, group O plasma, group antigens, gut, gut bacteria, hydrolase, logistics, matched donor, mucin O-glycans, muciniphila, plasma, potential utility, production, reaction, recipient blood group, recipients, red blood cells, removal, solution, source, source of enzymes, structural analysis, study, surface, target, transfusion, universal blood, utilization

Funders

  • Danish Agency for Science and Higher Education
  • Knut and Alice Wallenberg Foundation
  • Swedish Research Council
  • Government of Sweden
  • Novo Nordisk Foundation

Data Provider: Digital Science